Andreas Lennartsson
Affiliations: | Karolinska Institute, Stockholm, Sweden |
Google:
"Andreas Lennartsson"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Palau A, Segerberg F, Lidschreiber M, et al. (2023) Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells. Leukemia. 37: 1830-1841 |
| Romanova EI, Zubritskiy AV, Lioznova AV, et al. (2022) RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy. International Journal of Molecular Sciences. 23 |
| Ramilowski JA, Yip CW, Agrawal S, et al. (2020) Functional annotation of human long noncoding RNAs via molecular phenotyping. Genome Research |
| Dong W, Oya E, Zahedi Y, et al. (2020) Abo1 is required for the H3K9me2 to H3K9me3 transition in heterochromatin. Scientific Reports. 10: 6055 |
| Mujahed H, Miliara S, Neddermeyer AH, et al. (2020) AML Displays Increased CTCF Occupancy Associated to Aberrant Gene Expression and Transcription Factor Binding. Blood |
| Shahin Varnoosfaderani F, Palau A, Dong W, et al. (2020) A regulatory role for CHD2 in myelopoiesis. Epigenetics |
| Scialdone A, Khazaei S, Hasni MS, et al. (2019) Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies. Experimental Hematology |
| Miliara S, Kaczkowski B, Suzuki T, et al. (2018) Single-Cell Analysis of the Transcriptional Response in AML Patients Treated with BET-Inhibitors Blood. 132: 5120-5120 |
| Palau A, Garz AK, Diesch J, et al. (2017) Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes. Oncotarget. 8: 115002-115017 |
| Nilsson HJ, Montano G, Ullmark T, et al. (2017) The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells. Oncotarget. 8: 87136-87150 |